Detalhe da pesquisa
1.
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
J Infect Dis
; 224(8): 1345-1356, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387310
2.
A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
J Clin Microbiol
; 56(12)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257899
3.
Characterization of structural features and diversity of variable-region determinants of related quaternary epitopes recognized by human and rhesus macaque monoclonal antibodies possessing unusually potent neutralizing activities.
J Virol
; 85(20): 10730-40, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21835798
4.
Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.
J Virol
; 85(7): 3128-41, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270156
5.
Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.
Sci Rep
; 10(1): 13944, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811861
6.
Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry.
Tuberculosis (Edinb)
; 111: 178-187, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30029905
7.
Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.
Sci Rep
; 11(1): 19546, 2021 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580341
8.
The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.
J Virol
; 79(11): 6909-17, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15890930
9.
Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.
J Virol
; 79(2): 780-90, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15613306
10.
The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection.
J Virol
; 78(10): 5205-15, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15113902
11.
Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci.
J Immunol
; 169(1): 595-605, 2002 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12077293
12.
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
J Virol
; 76(18): 9035-45, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12186887